The New Era of Uterine Cancer: Genetics, Diagnosis, and Breakthrough Treatments

For Uterine Cancer Awareness Month, we sit down with two Upstate faculty: Dr. Jeffrey Ross, the David B. Jones/Robert F. Rohner Endowed Professor of Pathology and Medical Director at Foundation Medicine, and Dr. Allison Roy, Assistant Professor of Obstetrics and Gynecology. Together, they shed light on the rapidly evolving landscape of uterine cancer diagnosis and treatment. Dr. Roy shares how new therapies and clinical trials are offering fresh hope to patients, while Dr. Ross explains the critical role of genomic testing in shaping personalized cancer care. The conversation dispels common misconceptions about both molecular pathology and gynecologic oncology and highlights how genetic insights are revolutionizing uterine cancer detection, risk assessment, and treatment options. Tune in to learn why this is such an exciting, and hopeful, time in the fight against uterine cancer.